PlainRecalls

Acme United Corporation Recalls PhysiciansCare Brand Over-the-Counter Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

Reported: March 17, 2022 Initiated: March 17, 2022 #22733 About 165,000 units

Acme United of Rocky Mount, North Carolina issued this CPSC recall on March 17, 2022. Classified as Moderate severity. Approximately About 165,000 units are affected. The recall was issued because: The recalled over-the-counter products contain regulated substances (aspirin, acetaminophen, or ibuprofen) which must b…. This recall notice is sourced from official CPSC enforcement records. Below you will find the complete product description, hazard information, remedy instructions, and related recalls from the same manufacturer or product category.

Recall Insight

This CPSC action (record #22733) was formally reported on March 17, 2022. It is classified under Moderate severity, with a current status of Active. Acme United of Rocky Mount, North Carolina is listed as the recalling firm. Federal records indicate About 165,000 units are affected, a scale large enough to require multi-state distribution tracking.

The documented reason for this recall is: The recalled over-the-counter products contain regulated substances (aspirin, acetaminophen, or ibuprofen) which must be in child resistant packaging when being used in the household as required by the Poison Prevention… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately store the recalled products in a safe location out of reach of children and contact Acme United for information on how to dispose of or return the product and receive a f… — consumers holding this product should act on that instruction rather than relying on general guidance.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 1 were also issued by CPSC. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 4 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.

Recall Distribution by Severity Class

Severity1Class I (Critical)Class II (Moderate)Class III (Low)
Recall Distribution by Severity Class

Severity

Moderate

Units Affected

About 165,000

Related Recalls

6

1 from same agency

Product Description

This recall involves the PhysiciansCare brand Extra Strength Non Aspirin, Aspirin, Extra Strength Pain Reliever, Ibuprofen, Medication Station, and Multi-Pack over-the-counter drugs. The products contain aspirin, acetaminophen, or ibuprofen. They are packaged in cardboard boxes of 50, 100, 250, and 500 tablets per box. Product Drug Tablet Amount Extra Strength Non Aspirin Acetaminophen (500 mg) 50 tablets 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Aspirin Aspirin (325 mg) 50 tablets 100 tablets 250 tablets 500 tablets Extra Strength Pain Reliever Acetaminophen (250 mg) Aspirin (250 mg) 100 tablets 250 tablets Ibuprofen Ibuprofen (200 mg) 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Medication Station / Multi-Pack Acetaminophen (500 mg) Aspirin (325 mg) Ibuprofen (200 mg) Antacid (420 mg) 4 boxes of 100 tablets each with outer station 4 boxes of 100 tablets each without outer station The Antacid is not subject to this recall.

Reason for Recall

The recalled over-the-counter products contain regulated substances (aspirin, acetaminophen, or ibuprofen) which must be in child resistant packaging when being used in the household as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Remedy

Consumers should immediately store the recalled products in a safe location out of reach of children and contact Acme United for information on how to dispose of or return the product and receive a full refund. Acme United is contacting all purchasers directly.

Recall Profile

Structured summary of the CPSC recall record
Attribute Value
Agency U.S. Consumer Product Safety Commission
Severity class Moderate
Status Active
Recall number 22733
Date reported March 17, 2022
Date initiated March 17, 2022
Recalling firm Acme United of Rocky Mount, North Carolina
Units affected About 165,000
Distribution Not disclosed

Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.

Scale of Impact

About 165,000 units affected — multi-state distribution scale.

Regional (<10K units)
Multi-state (10K – 100K units)
Large-scale (100K – 1M units) ✓ This recall
Massive (≥1M units)

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Consumer Product Safety Commission filings.

Frequently Asked Questions

What product was recalled?
This recall involves the PhysiciansCare brand Extra Strength Non Aspirin, Aspirin, Extra Strength Pain Reliever, Ibuprofen, Medication Station, and Multi-Pack over-the-counter drugs. The products contain aspirin, acetaminophen, or ibuprofen. They are packaged in cardboard boxes of 50, 100, 250, and 500 tablets per box. Product Drug Tablet Amount Extra Strength Non Aspirin Acetaminophen (500 mg) 50 tablets 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Aspirin Aspirin (325 mg) 50 tablets 100 tablets 250 tablets 500 tablets Extra Strength Pain Reliever Acetaminophen (250 mg) Aspirin (250 mg) 100 tablets 250 tablets Ibuprofen Ibuprofen (200 mg) 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Medication Station / Multi-Pack Acetaminophen (500 mg) Aspirin (325 mg) Ibuprofen (200 mg) Antacid (420 mg) 4 boxes of 100 tablets each with outer station 4 boxes of 100 tablets each without outer station The Antacid is not subject to this recall.. Recalled by Acme United of Rocky Mount, North Carolina. Units affected: About 165,000.
Why was this product recalled?
The recalled over-the-counter products contain regulated substances (aspirin, acetaminophen, or ibuprofen) which must be in child resistant packaging when being used in the household as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
What should consumers do?
Consumers should immediately store the recalled products in a safe location out of reach of children and contact Acme United for information on how to dispose of or return the product and receive a full refund. Acme United is contacting all purchasers directly.
Which agency issued this recall?
This recall was issued by the CPSC on March 17, 2022. Severity: Moderate. Recall number: 22733.
How do I check if my product is affected by a recall?
Check the product description and recall number (22733) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product?
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.

Recall Context

Product recalls are issued when a manufacturer, distributor, or federal agency determines that a product poses a safety risk to consumers. This recall is classified as moderate severity, indicating the product may cause temporary or medically reversible health consequences. Across PlainRecalls, we track 83,000+ recalls from FDA, CPSC, and NHTSA to help consumers stay informed and act quickly when safety issues arise.

Nearby Recalls in This Category

Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, … →

Data Sources

Data as of 2025. Source: FDA, CPSC, NHTSA, USDA FSIS federal recall databases.

  • Source: FDA — Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
  • Source: CPSC — Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
  • Source: NHTSA — National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)
  • Source: USDA FSIS — Food Safety and Inspection Service (meat, poultry, and egg product recalls)

Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.

All federal data sources used on this page

Source: Federal recall agencies (FDA, CPSC, NHTSA, USDA FSIS) Aggregated multi-agency recall feeds · 2024 Recall data normalized across federal agency feeds; severity classifications follow each agency's own taxonomy (FDA Class I/II/III; CPSC, NHTSA, USDA FSIS).